Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Dec 11.
Published in final edited form as: Tetrahedron Asymmetry. 2017 Apr 2;73(26):3643–3651. doi: 10.1016/j.tet.2017.03.092

Scalable synthesis of enaminones utilizing Gold’s reagents

Alexander W Schuppe 1, James M Cabrera 1, Catherine LB McGeoch 1, Timothy R Newhouse 1,*
PMCID: PMC6905625  NIHMSID: NIHMS1016664  PMID: 31827315

Abstract

Several Gold’s reagents were synthesized from cyanuric chloride and N,N-dialkylformamides. These synthetic equivalents of N,N-dimethylformamide dimethyl acetal were used in an optimized and scalable procedure for the regioselective synthesis of a variety of enaminones from ketone starting materials, whose utility was demonstrated by the stereoselective synthesis of Rawal-type dienes.

Keywords: Enaminones, Rawal diene, Diels-Alder

1. Introduction

The use of dienes with electron-donating groups in the Diels-Alder reaction leads to increased rates of reaction, thus allowing for more mild reaction conditions and broader functional group compatibility.1 In particular, Danishefsky- and Rawal-type dienes,2,3 which possess two constructively oriented electron-donating groups, have been widely used in natural product synthesis.4,5 This is because of their ease of preparation, increased reactivity toward thermal cycloadditions, and the utility of the oxidation states introduced as the heteroatom substituents.2,3 Both of these types of dienes have been conveniently prepared by enolization and trapping of a β-substituted enone – a β-methoxy enone in the case of Danishefsky dienes and an enaminone for Rawal dienes.2,3

Enaminones, which are also powerful building blocks for heterocycle formation and Michael addition-elimination reactions,610 are usually accessed through functionalization of a ketone directly with N,N-dimethylformamide dimethyl acetal (2, DMF-DMA)11 or Bredereck’s reagent (3)12 as shown in Fig. 1a. While this approach is simple and direct, it can lead to non-selective enolization and thus constitutional isomeric products wherein the two different ketone a-positions have been functionalized (e.g. 4a and 4b). This problem has been circumvented through stepwise enone formation via β-elimination of an acetal formed from trimethylorthoformate, followed by addition-elimination with dimethylamine (Fig. 1b).13 It is noteworthy that this latter approach allows for the synthesis of a wide variety of β-amino substituted enones from a single β-methoxy enone precursor.

Fig. 1.

Fig. 1.

Enaminone formation from ketones by multiple approaches.

During the course of a total synthesis of andirolide N,14 we examined these conventional approaches for enaminone synthesis and ultimately found the most scalable approach utilized the aminomethylene electrophile equivalent (5), known as Gold’s reagent.1517 This approach allowed for the direct regio- and diastereoselective functionalization of 2-butanone using Gold’s reagent, a bench stable reagent which can be prepared in a single step and purified by recrystallization.17 The straightforward preparation of this valuable equivalent to DMF-DMA employs inexpensive cyanuric chloride and DMF. In this report we describe the synthesis of a small library of sterically and electronically varied Gold’s reagents using readily available formamides, and investigate their utility in enaminone synthesis.

2. Results and discussion

2.1. Synthesis of a library of Gold’s reagents

In order to expand the synthetic utility of Gold’s reagents, various [3-(dialkylamino)-2-azaprop-2-en-1-ylidene]dialkylammonium chloride salts (5) were synthesized, and an improved procedure for the preparation of the tetramethyl analog (5a) was developed.17 The synthesis of these reagents proceeded smoothly by heating one equivalent of cyanuric chloride (6) and six equivalents of N,N-dialkylformamide, either neat or using 1,4-dioxane as solvent (5a, 5b, 5e, and 5g), to produce three equivalents of the corresponding Gold’s reagent (5, Scheme 1). It should be noted that during the course of this exothermic reaction three equivalents of CO2 are produced, and thus caution should be exercised when this reaction is performed on large scale.

Scheme 1.

Scheme 1.

Formation of Gold’s reagents using formamidesa-d. aIsolated yield. b1,4-dioxane was used as solvent (4 M). c3 equiv of formamide was used. d4 equiv of formamide was used.

Careful control of the temperature was critical for minimizing byproduct formation during the exothermic release of CO2. Concomitant with the release of CO2 was a distinct change in color of the reaction mixture to a dark red or brown, occurring at a different temperature for each substrate. As a precaution, a modified protocol involving a double-walled reflux condenser and an oil-bubbler outlet was employed (see Supplementary Materials) for the scalable synthesis of the parent methyl-substituted Gold’s reagent (5a). While this procedure was successful on a 50-g scale to provide 120 g of 5a in 97% yield, further optimization is likely necessary for larger scale preparations due to the exotherm and gas release.

Using this protocol, a number of Gold’s reagents could be prepared, as depicted in Scheme 1. Ethyl substitution on the formamide yielded the corresponding ethyl Gold’s reagent (5b) in 63% yield. Activated alkyl substituents, such as allyl (5c) and benzyl (5d), were also tolerated in the synthesis of the corresponding Gold’s reagents in 69% and 47% yield, respectively. The synthesis of several reagents derived from cyclic formamides proceeded well: pyrrolidine (5e), piperidine (5f), morpholine (5g), and indoline (5h) Gold’s reagents were synthesized in 74–91% yield. In order to observe complete conversion for some of the more challenging substrates (5c, 5d, 5e, and 5g), fewer equivalents of the formamide were used relative to cyanuric chloride. Purification of the Gold’s reagents could be readily performed by simple trituration with combinations of ethereal and hydrocarbon solvents.

2.2. Development of optimized conditions for the transformation of ketones to enaminones

With a library of novel Gold’s reagents in hand, we turned to optimization of the conditions for enaminone formation (Table 1). Previous conditions described by Gupton and co-workers16a employed using the newly synthesized Gold’s reagents were ineffective, thus alternative reaction conditions were examined. Optimization efforts focused on variation of the base employed along with modification of solvent and temperature (Table 1).

Table 1.

Optimization of enaminone formation.a

graphic file with name nihms-1016664-t0004.jpg
Entry Base Solvent % Yielda
1 MeONa MeOH <5
2 i-PrONa i-PrOH 29
3 t-BuONa t-BuOH 0
4 t-BuONa THF 24
5 t-BuOK THF <5
6 t-BuOLi THF 96
a

Yield determined by 1H-NMR analysis after aqueous work-up using 1,3,5-trimethoxybenzene as an internal standard.

When the previously described conditions using NaOMe in MeOH16a or NaO-i-Pr in i-PrOH15 were employed for the transformation of 1b to 4c, modest yields up to 29% were observed (Entries 1 and 2). Alteration of the alkoxide base to NaO-t-Bu in t-BuOH did not result in product formation (Entry 3). Use of THF as solvent resulted in an improved yield (Entry 4), and it was found that the optimal counterion of the tert-butoxide base was lithium (Entry 6), which resulted in formation of the product 4c in 96% yield. Metal amide bases (LiHMDS, NaHMDS, KHMDS, LDA, and LiTMP) were also investigated but led to only modest yields of enaminone 4c.

2.3. Substrate scope of the formation of enaminones with Gold’s reagents

After the reaction conditions for enaminone formation had been optimized with acetophenone, the generality of these conditions was probed by testing the library of Gold’s reagents (Scheme 2A). By using acetophenone to directly compare the efficiency of enaminone formation with various Gold’s reagents, it was found that the corresponding enaminones (4c-4i) were prepared with similar efficiencies.

Scheme 2.

Scheme 2.

Substrate scope of enaminone formation.

The reaction conditions utilizing dimethyl Gold’s reagent (5a) could be employed to synthesize an intermediate (4j) en route to an FDA approved treatment for non-small cell lung carcinoma, osimertinib,18b in 94% yield, which has previously been reported to proceed in 84% yield using commercially available DMF-DMA.18 Derivatization of commercially available terpene compounds, dihydro-β-ionone and geranylacetone, with Gold’s reagent (5h and 5f respectively) led to regioselective formation of the heterocyclic enaminones 4k and 4l at the less hindered primary position in 56% and 62% yield. Functionalization of γ-butyrolactone with 5g resulted in the synthesis of the morpholine-derived enaminone (4m) in 74% yield.

In order to demonstrate the scalability of the newly developed reaction conditions, we applied them in the synthesis of enaminone 4b, which was required for the total synthesis of andirolide N. Reaction of 2-butanone (1a) and 5a on 1-mol scale provided enaminone 4b in 73% yield after vacuum distillation (Scheme 2B), which is a notable improvement over the previously reported yield of 48%.15 The modified procedure additionally replaced the alcoholic solvent used in reaction workup with diethyl ether to allow for a facile extractive isolation and recovery of product.

2.4. Diastereoselective Rawal diene synthesis

As a demonstration of the utility of enaminones, the substrate 4b was converted to the diastereomeric Rawal-type dienes 7a and 7b as shown in Table 2. While not previously examined in detail,19,20 we hypothesized that the identities of the amide base and additives used would be crucial for controlling enoxysilane geometry.21 Indeed, 7a and 7b could be formed diastereoselectively through simply modifying these parameters.

Table 2.

Diastereoselective Rawal diene synthesis.ac

graphic file with name nihms-1016664-t0005.jpg
Entry Base Additives % Yielda E/Z Ratio
1 LiTMP LiCI, DMPU 59%b >20:1
2 LiTMP DMPUc 46% 20:1
3 LiTMP DMPU 74% 10:1
4 LiTMP none 30% 2:1
5 LiHMDS DMPU 63%b 1:10
6 LiHMDS none 23% 2:1
7 NaHMDS none 71% 1:1
8 KHMDS none 92% 2:1
a

Yield determined by 1H-NMR analysis after aqueous work-up using 1,2,4,5-tetramethylbenzene as an internal standard.

b

Isolated yield after vacuum distillation.

c

4b was pre-mixed with TIPSCl (2 equiv) before addition of base.

Formation of the E-diene (7a) could be performed selectively (>20:1 E:Z) by deprotonation with lithium 2,2,6,6-tetrame-thylpiperidine (LiTMP) in the presence of LiCl (0.3 equiv)21a and DMPU (1 equiv), with TIPSCl as the silylating agent (Entry 1). Slightly diminished yield was observed using inverse order of addition, wherein TIPSCl was pre-mixed with DMPU (1 equiv) and 4b prior to the introduction of LiTMP (Entry 2).22 LiCl was an essential additive for maintaining high levels of diastereoselectivity – a 10:1 ratio was observed in its absence (Entry 3), and exclusion of DMPU led to even further diminished diastereoselectivity (2:1) (Entry 4). Reversal of the diastereoselectivity to form the Z-diene (7b) in a 1:10 E:Z ratio was observed when LiHMDS with DMPU was employed (Entry 5). Comparison of HMDS amides in the absence of DMPU displayed similarly modest diastereoselectivities (Entries 6–8).20a Although modest diastereoselectivity was observed with KHMDS, these reaction conditions provided the highest yield (Entry 8). Other lithium amides (LDA or LiNCy2) were less successful.

The origin of diastereoselection is worthy of comment. While minimization of 1,3-diaxial interactions in chair-like transition states or reactions that proceed via more open transition states are generally used to rationalize diastereoselective enolate formation,23 these results suggest other factors may be operable.21b

3. Conclusion

This report details the synthesis of a library of Gold’s reagents, which were shown to be generally effective for ketone and ester one-carbon homologation to form enaminones. An enaminone recently employed in the synthesis of andirolide N14 was prepared on mole scale and conditions were described to selectively form E-and Z-Rawal-type dienes. We hope that the development of these scalable processes will enable broader application of Gold’s reagents to challenges in multistep synthesis.

4. Experimental

4.1. General experimental

4.1.1. General experimental procedures

All reactions were carried out under an inert nitrogen atmosphere with dry solvents under anhydrous conditions unless otherwise stated. All reactions were capped with a rubber septum or Teflon-coated silicon microwave cap unless otherwise stated. Stainless steel cannula or syringes were used to transfer solvent, and air- and moisture-sensitive liquid reagents. Reactions were monitored by thin-layer chromatography (TLC) and carried out on 0.25 mm Merck silica gel plates (60F-254) using UV light as the visualizing agent and potassium permanganate, an acidic solution of p-anisaldehyde, and Seebach as developing agents. Flash column chromatography employed SiliaFlash® P60 (40–60 μm, 230–400 mesh) silica gel purchased from SiliCycle Inc.

4.1.2. Materials

All reaction solvents were purified using a Seca solvent purification system by Glass Contour, with the exception of methanol, iso-propyl alcohol, and tert-butyl alcohol. Methanol was purified by distillation over magnesium, and anhydrous iso-propyl alcohol, tert-butyl alcohol, and 1,4-dioxane were purchased from Sigma-Aldrich and used as received. N,N-dicyclohexylamine, 2,2,6,6-tetramethylpiperidine, and DMPU were distilled over CaH2. n-butyllithium (in hexanes) was purchased from Sigma-Aldrich. The molarity of n-butyllithium solutions were determined by titration with N-benzylbenzamide. All other reagents were used as received without further purification, unless otherwise stated.

4.1.3. Instrumentation

All new compounds were characterized by means of 1H NMR, 13C NMR, FT-IR(thin film from CH2Cl2), and HR-MS. Copies of the 1H and 13C NMR spectra can be found in the supplementary materials. NMR spectra were recorded using a Varian 400 MHz NMR spectrometer, Varian 500 MHz NMR spectrometer, or a Varian 600 MHz NMR spectrometer. All 1H NMR data are reported in δ units, parts per million (ppm), and were calibrated relative to the signals for residual chloroform (7.26 ppm) in deuterochloroform (CDCl3). All 13C NMR data are reported in ppm relative to CDCl3 (77.16 ppm) and were obtained with 1H decoupling unless otherwise stated. The following abbreviations or combinations thereof were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet, and a = apparent. All IR spectra were taken on an FT-IR/Raman Thermo Nicolet 6700. High resolution mass spectra (HR-MS) were recorded on a Bruker microTOF mass spectrometer using ESI-TOF (electrospray ionization-time of flight).

4.2. Experimental procedures

4.2.1. Methyl Gold’s reagent (5a)

[CAUTION!]: This reaction produces a large amount of CO2 gas and thus appropriate reaction setup should be used (see Supplementary Materials for pictures of reaction setup).

To a flame-dried 500-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (50.0 g, 271 mmol, 1.0 equiv). The solid was diluted with 1,4-dioxane (67 mL, 4 M). To the stirred heterogeneous mixture was added N,N-dimethylformamide (126 mL, 1.6 mol, 6 equiv) dropwise over 20 min at room temperature, which resulted in a pale yellow heterogeneous mixture.

The reaction vessel was fitted with a flame-dried 45-cm double walled reflux condenser with a mineral oil bubbler outlet connected to the top of the condenser. The reaction apparatus was transferred to a room temperature oil bath that was then warmed to 90 °C. When the oil bath temperature had reached 85 °C (ca.30 min), the reaction mixture turned dark red, and exothermic release of CO2 commenced. After stirring at 90 °C for two additional hours, the reaction mixture was removed from the oil bath and cooled to room temperature. Once at room temperature, a dark brown solid formed. The crude brown solid was purified by trituration with pentane (3 × 200 mL). The resulting solid was dried under vacuum to provide the title compound as a light brown solid (127 g, 97%). 1H NMR (600 MHz, CDCl3): δ 9.79 (s, 2H), 3.40 (s, 6H), 3.21 (s, 6H) 13C NMR (151 MHz, CDCl3): δ 168.4, 42.7, 36.2 IR(cm−1): 3389, 2933, 1604, 1417, 1341, 1124, 1065, 829, 531 ESI-HRMS (m/z): [M - Cl]+ calc’d for C6H14N3+: 128.1182; found: 128.1183.

4.2.2. Ethyl Gold’s reagent (5b)

To a flame-dried 25-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (1.0 g, 5.4 mmol, 1.0 equiv) and the stirred solid was diluted with 1,4-dioxane (1.4 mL, 4 M). To the stirred heterogeneous mixture was added N,N-diethylformamide (3.6 mL, 32.5 mmol, 6 equiv) dropwise over 5 min at room temperature. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a room temperature oil bath that was then warmed to 85 °C. When the oil bath temperature had reached 85 °C the reaction mixture turned dark red, and exothermic release of CO2 commenced. After stirring at 85 °C for two hours, the reaction was removed from the oil bath and cooled to room temperature. Once at room temperature, a dark brown solid formed. The crude brown solid was purified by trituration with pentane (5 × 4 mL). The resulting solid was concentrated under reduced pressure by rotary evaporation to reveal the title compound as a light brown solid (2.24 g, 63%). 1H NMR (500 MHz, CDCl3): δ 9.67 (s, 2H), 3.67 (q, J = 7.2 Hz, 4H), 3.62 (q, J = 7.2 Hz, 4H), 1.35 (t, J = 7.2 Hz, 6H), 1.23 (t, J = 7.2, Hz, 6H) 13C NMR (151 MHz, CDCl3): δ 167.5, 48.3, 41.8, 14.3, 12.4 IR (cm−1): 3408, 2977, 1706, 1586, 1446, 1341, 1273, 1234, 1138, 994, 764 ESI-HRMS (m/z): [M - Cl]+ calc’d for C10H22N3+: 184.1808; found: 184.1807.

4.2.3. Allyl Gold’s reagent (5c)

To a flame-dried 25-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (1.0 g, 5.4 mmol, 1.0 equiv). To the stirred solid was added N,N-diallylformamide24 (2.03 g, 16.3 mmol, 3.0 equiv) dropwise over 5 min at room temperature. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a room temperature oil bath that was then warmed to 100 °C. When the oil bath temperature had reached 80 °C the reaction mixture gradually turned dark brown, and exothermic release of CO2 commenced. After stirring at 100 °C for one hour, the reaction was removed from the oil bath and cooled to room temperature. Once at room temperature, a black oil formed, which was washed with Et2O (5 × 5 mL), and the ethereal layer was discarded. The oil was concentrated under reduced pressure by rotary evaporation to reveal the title compound as a black oil (1.51 g, 69%). 1H NMR (600 MHz, CDCl3): δ 9.86 (s, 2H), 5.86–5.80 (m, 2H), 5.73–5.67 (m, 2H), 5.40–5.38 (m, 3H), 5.33 (at, J = 9.6 Hz, 3H), 5.25 (ad, J = 17.4 Hz, 2H), 4.23 (dd, J = 25.8, 6.6 Hz, 8H) 13C NMR (151 MHz, CDCl3): δ 168.7, 130.5, 129.3, 122.1, 120.8, 55.5, 48.8 IR (cm−1): 3390, 2932, 2077, 1709, 1572, 1441, 1418, 1332, 1235, 1170, 929, 844 ESI-HRMS (m/z): [M - Cl]+ calc’d for C14H22N3+: 232.1808; found: 232.1828.

4.2.4. Benzyl Gold’s reagent (5d)

To a flame-dried 25-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (752 mg, 3.33 mmol, 1.0 equiv). To the stirred solid was added N,N-dibenzylformamide (1.0 g, 32.5 mmol, 4.0 equiv) in one portion at room temperature. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a room temperature oil bath that was then warmed to 120 °C. Once the oil bath temperature had reached 75 °C, the solids gradually melted to form a red-orange solution, and exothermic release of CO2 commenced. After stirring at 120 °C for one hour, the reaction was removed from the oil bath and cooled down to room temperature. Once at room temperature, a yellow-orange solid formed.

To the reaction vessel containing the crude yellow solid was added THF (2 mL) and the mixture was heated to reflux until complete dissolution of solid was observed. Once the solid dissolved, hexanes (6 mL) was added and a yellow solid precipitated after cooling to room temperature. The liquid was decanted and the resulting solid was triturated with hexanes/THF (2:1, 2 × 6 mL). Residual solvent was removed by concentration under reduced pressure to yield the title compound as a yellow solid (1.47 g, 47%). 1H NMR (600 MHz, CDCl3): δ 10.63 (s, 2H), 7.44–7.33 (m, 16H), 7.14–7.13 (m, 4H), 4.74 (s, 4H), 4.71 (s, 4H) 13C NMR (151 MHz, CDCl3): δ 169.7, 133.2, 132.9, 129.4, 129.3, 129.3, 129.1, 128.8, 128.4, 56.5. 48.9 IR (cm−1): 1589, 1568, 1496, 1453, 1344, 1215, 755, 701 ESI-HRMS (m/z): [M - Cl]+ calc’d for C30H30N3+: 432.2458; found: 432.2434.

4.2.5. Pyrrolidine Gold’s reagent (5e)

To a flame-dried 25-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (1.0 g, 5.4 mmol, 1.0 equiv) and diluted with 1,4-dioxane (1.4 mL, 4 M). To the stirred heterogeneous mixture was added 1-formylpyrrolidine (2.1 mL, 22 mmol, 4.0 equiv) dropwise over 5 min at room temperature. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a room temperature oil bath that was then warmed to 85 °C. Once the oil bath temperature had reached 50 °C, a white precipitate formed in the yellow reaction mixture. When the oil bath temperature reached 85 °C the reaction mixture turned dark red, and exothermic release of CO2 commenced. After stirring at 85 °C for two hours, the reaction was removed from the oil bath and cooled to room temperature. Once at room temperature, a red-brown oil formed. The crude brown solid was purified by trituration with pentane (3 × 5 mL). The pentane layer was discarded and the oil was concentrated under reduced pressure by rotary evaporation to reveal the title compound as a red-brown solid (1.9 g, 82%). 1H NMR (400 MHz, CDCl3): δ 9.64 (s, 2H), 3.90 (t, J = 6.4 Hz, 4H), 3.64 (t, J = 6.4 Hz, 4H), 2.05–2.02 (m, 8H) 13C NMR (151 MHz, CDCl3): δ 164.6, 51.2, 47.6, 25.0, 24.2 IR (cm−1): 3392, 2975, 1706, 1581, 1450, 1306, 1110, 855 ESI-HRMS (m/z): [M - Cl]+ calc’d for C10H18N3+: 180.1495; found: 180.1495.

4.2.6. Piperidine Gold’s reagent (5f)

To a flame-dried 25-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (270 mg, 1.47 mmol, 1.0 equiv). To the stirred solid was added 1-formylpiperdine (1.0 g, 8.8 mmol, 6.0 equiv) dropwise over 5 min at room temperature. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a room temperature oil bath that was then warmed to 100 °C. Once the oil bath temperature had reached 90 °C, the reaction mixture gradually turned a dark brown color and exothermic release of CO2 commenced. After stirring at 100 °C for two hours, the reaction was removed from the oil bath and cooled to room temperature. Once at room temperature, a red-orange solid formed.

To the reaction vessel containing the crude red solid was added THF (2 mL), and the mixture was heated to reflux until complete dissolution of solid was observed. Once the solid dissolved, hexanes (6 mL) was added, and a red solid formed. The mixture was allowed to slowly cool to room temperature and the red solid was washed with hexanes/THF (2:1, 2 × 6 mL), and concentrated under reduced pressure to yield the title compound as a red solid (928 mg, 85%). 1H NMR (600 MHz, CDCl3): δ 9.71 (s, 2H), 3.75 (adt, J = 15.6, 5.4 Hz, 8H), 1.78–1.72 (m, 8H), 1.69–1.66 (m, 4H) 13C NMR (151 MHz, CDCl3): δ 166.4, 53.1, 45.4, 26.6, 25.5, 23.9 IR (cm−1): 3398, 2940, 1588, 1449, 1362, 1335, 1222, 1113, 1024, 1000 ESI-HRMS (m/z): [M - Cl]+ calc’d for C12H22N3+: 208.1808; found: 208.1808.

4.2.7. Morpholine Gold’s reagent (5g)

To a flame-dried 25-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (1.2 g, 6.5 mmol, 1.0 equiv) and the stirred solid was diluted with 1,4-dioxane (1.6 mL, 4 M). To the stirred heterogeneous mixture was added 4-formylmorpholine (1.9 mL, 19 mmol, 3 equiv) dropwise over 5 min at room temperature. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a room temperature oil bath that was then warmed to 85 °C. Once the oil bath temperature had reached 85 °C, the reaction mixture turned a dark red color and exothermic release of CO2 commenced. After stirring at 85 °C for one hour, the reaction was removed from the oil bath and cooled to room temperature. Once at room temperature, a brown oil formed. The crude oil was purified by washing with Et2O/pentane (3:1, 2 × 4 mL). The ethereal layer was discarded and the oil was dried under vacuum overnight (ca.100 mtorr) to reveal the title compound as a brown solid (2.18 g, 91%). 1H NMR (600 MHz, CDCl3): δ 9.87 (s, 2H), 3.90–3.88 (at, J = 4.2 Hz, 4H), 3.87–3.84 (m, 8H), 3.76 (at, J = 4.8 Hz, 4H) 13C NMR (151 MHz, CDCl3): δ 167.1, 67.1, 66.1, 51.8, 45.2 IR (cm−1): 3386, 2931, 1709, 1585, 1442, 1341, 1261, 1235, 1174, 1110, 1021, 856, 617 ESI-HRMS (m/z): [M - Cl]+ calc’d for C10H18N3O2+: 212.1394; found: 212.1393.

4.2.8. Indoline Gold’s reagent (5h)

To a flame-dried 25-mL round-bottomed flask equipped with a magnetic stir bar was added cyanuric chloride (128 mg, 1.13 mmol, 1.0 equiv). To the stirred solid was added 1-formylindoline (1.0 g, 6.79 mmol, 6.0 equiv)25 in one portion at room temperature. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a room temperature oil bath that was then warmed to 115 °C. Once the oil bath temperature had reached 75 °C, the solids gradually melted to form an orange mixture, which turned dark red at 95 °C and exothermic release of CO2 commenced. After stirring at 115 °C for one hour, the reaction was removed from the oil bath and cooled to room temperature. Once at room temperature, an orange solid formed.

To the reaction vessel containing the crude orange solid was added THF (2 mL) and the mixture was heated to reflux until complete dissolution of solid was observed. Once the solid dissolved, hexanes (6 mL) was added, and an orange solid precipitated after cooling to room temperature. The liquid was decanted and the resulting solid was triturated with hexanes/THF (2:1, 2 × 6 mL). Residual solvent was removed by concentration under reduced pressure to yield the title compound as an orange solid (782 mg, 74%). 1H NMR (600 MHz, CDCl3): δ 11.12 (s, 2H), 8.08 (d, J = 10.2 Hz, 2H), 7.38 (t, J = 9.0 Hz, 2H), 7.29 (d, J = 9.0 Hz, 2H), 7.27–7.24 (m, 2H), 4.34 (t, J = 9.0 Hz, 4H), 3.33 (t, J = 9.0 Hz, 4H) 13C NMR (151 MHz, CDCl3): δ 160.8, 139.6, 133.6, 129.3, 128.3, 126.0, 114.5, 48.3, 27.5 IR (cm−1): 3368, 2933, 1681, 1602, 1575, 1416, 1342, 1123, 766 ESI-HRMS (m/z): [M - Cl]+ calc’d for C18H18N3+: 276.1495; found: 276.1495.

4.2.9. General procedure for enaminone formation

An evacuated flame-dried 5-mL microwave vial equipped with magnetic stir bar was brought into a glovebox. Once in the glove-box, the flask was filled with nitrogen atmosphere. Solid LiO-t-Bu (17.6 mg, 0.22 mmol, 1.1 equiv) was added and the vial was sealed. The reaction vessel was removed from the glovebox, and the vial was evacuated and backfilled with nitrogen three times.

To the reaction vessel containing stirred solid LiO-t-Bu, was added THF (0.4 mL, 0.5 M) at room temperature. To the stirred reaction mixture was added the corresponding ketone (0.2 mmol, 1.0 equiv) dropwise over one minute at room temperature. After stirring at room temperature for 30 min, the corresponding Gold’s reagent (0.22 mmol, 1.1 equiv) was added in one portion. The reaction vessel was sealed with a Teflon vial microwave cap, and transferred to a pre-warmed oil bath set to 65 °C. After stirring for the stated time, the reaction was removed from the oil bath, cooled to room temperature, and diluted with sat. aq. NH4Cl (5 mL). The layers were separated, and the aqueous layer was extracted with chloroform (3 × 5 mL). The combined organics were washed with brine (5 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure by rotary evaporation to give crude enaminone. Purification by flash column chromatography on silica gel or trituration afforded the title compound.

4.2.10. Diethyl enaminone of acetophenone (4c)

The title compound was prepared according to the general procedure with acetophenone (23 μL, 0.20 mmol, 1.0 equiv) and ethyl Gold’s reagent (5b, 47 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 12 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 30%–60%) to yield the title compound (35.3 mg, 88%) as a tan solid. Rf: 0.19 (65% ethyl acetate/hexanes) 1H NMR (600 MHz, CDCl3): δ 7.88 (d, J = 7.2 Hz, 2H), 7.82 (d, J = 12.6 Hz, 1H), 7.46–7.40 (m, 3H), 5.77 (d, J = 12.6 Hz, 1H), 3.38–3.27 (m, 4H), 1.24 (t, J = 6.0 Hz, 6H) 13C NMR (151 MHz, CDCl3): δ 188.9, 152.5, 140.9, 130.9, 128.2, 127.6, 91.8, 50.7, 42.9, 15.0, 11.7 IR (cm−1): 2975, 2929, 2280, 2188, 2177, 2025, 1992, 1981, 1959, 1640, 1598, 1582, 1547, 1469, 1365, 1282, 1219, 1078, 658 ESI-HRMS (m/z): [M+H]+ calc’d for C13H18NO+: 204.1383; found: 204.1384.

4.2.11. Diallyl enaminone of acetophenone (4d)

The title compound was prepared according to the general procedure with acetophenone (23 μL, 0.20 mmol, 1.0 equiv) and allyl Gold’s reagent (5c, 59 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 12 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 20%–45%) to yield the title compound (29.5 mg, 65%) as a yellow oil. Rf: 0.14 (30% ethyl acetate/hexanes) 1H NMR (600 MHz, CDCl3): δ 7.88–7.85 (m, 3H), 7.46–7.39 (m, 3h), 5.84 (d, J = 12.6 Hz, 1H), 5.83–5.75 (m, 2H), 5.26 (d, J = 10.2 Hz, 2H), 5.22 (d, J = 16.9 Hz, 2H), 3.92–3.84 (m, 4H) 13C NMR (151 MHz, CDCl3): δ 189.2, 153.2, 140.6, 133.0, 131.1, 130.6, 128.3, 127.7, 119.2, 118.1, 93.2, 58.6, 50.6 IR (cm−1): 2922, 2853, 2214, 1597, 1581, 1546, 1447, 1365, 1274, 1312, 1206, 1051, 1024, 997, 703 ESI-HRMS (m/z): [M+H]+ calc’d for C15H18NO+: 228.1383; found: 228.1382.

4.2.12. Dibenzyl enaminone of acetophenone (4e)

The title compound was prepared according to the general procedure with acetophenone (23 μL, 0.20 mmol, 1.0 equiv) and benzyl Gold’s reagent (5d, 103 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 12 h. The crude oil was purified by flash column chromatography on silica gel (Et2O/DCM = 2%–10%) to yield the title compound (57.2 mg, 87%) as an orange solid. Rf: 0.30 (5% Et2O/DCM) 1H NMR (500 MHz, CDCl3): δ 8.18 (d, J = 12.5 Hz, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.46–7.32 (m, 9H), 7.22 (d, J = 7.0 Hz, 3H), 6.02 (d, J = 13.0 Hz, 1H), 4.47 (brs, 2H), 4.38 (brs, 2H) 13C NMR (151 MHz, CDCl3): δ 189.4, 154.3, 140.4, 135.9, 135.3, 131.2, 129.1, 128.8, 128.7, 128.3, 128.0, 127.7, 127.4, 93.3, 59.5, 50.9 IR (cm−1): 3028, 2923, 1641, 1597, 1580, 1544, 1452, 1361, 1201, 1076, 1050, 1025, 754, 698 ESI-HRMS (m/z): [M+H]+ calc’d for C23H22NO+: 328.1696; found: 328.1703.

4.2.13. Pyrrolidine enaminone of acetophenone (4f)

The title compound was prepared according to the general procedure with acetophenone (23 μL, 0.20 mmol, 1.0 equiv) and pyrrolidine Gold’s reagent (5e, 47 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 12 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 30%–60%) to yield the title compound (57.2 mg, 88%) as a tan solid. Rf: 0.12 (50% ethyl acetate/hexanes) 1H NMR (500 MHz, CDCl3): δ 8.03 (d, J = 12.5 Hz, 1H), 7.89 (d, J = 7.0, 2H), 7.46–7.39 (m, 3H), 5.68 (d, J = 12.5 Hz, 1H), 3.57 (brs, 2H), 3.29 (brs, 2H), 2.04 (brs, 2H), 1.95 (brs, 2H) 13C NMR (151 MHz, CDCl3): δ 188.4, 150.0, 140.5, 130.8, 128.1,127.5, 93.1, 52.4, 47.0, 25.2 IR (cm−1): 2917, 2849, 1639, 1582, 1548, 1364, 1341, 1272, 1218, 1052, 757 ESI-HRMS (m/z): [M+H]+ calc’d for C13H16NO+: 202.1226; found: 202.1222.

4.2.14. Piperidine enaminone of acetophenone (4g)

The title compound was prepared according to the general procedure with acetophenone (23 μL, 0.20 mmol, 1.0 equiv) and piperidine Gold’s reagent (5f, 54 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 12 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 40%–70%) to yield the title compound (32.4 mg, 75%) as a light yellow solid. Rf: 0.15 (50% ethyl acetate/hexanes) 1H NMR (500 MHz, CDCl3): δ 7.88 (d, J = 7.0 Hz, 2H), 7.78 (d, J = 12.5 Hz, 1H), 7.45–7.38 (m, 3H), 5.81 (d, J = 12.5 Hz, 1H), 3.36 (brs, 4H), 1.66 (brs, 6H) 13C NMR (126 MHz, CDCl3): δ 189.1, 153.2, 140.8, 130.9, 128.2, 127.5, 91.3, 24.2 IR (cm−1): 2937, 2854, 1638, 1597, 1581, 1544, 1462, 1448, 1367, 1312, 1275, 1209, 1116, 1053, 1024, 881, 704, 660 ESI-HRMS (m/z): [M+H]+ calc’d for C14H18NO+: 216.1383; found: 216.1386.

4.2.15. Morpholine enaminone of acetophenone (4h)

The title compound was prepared according to the general procedure with acetophenone (23 μL, 0.20 mmol, 1.0 equiv) and morpholine Gold’s reagent (5g, 54 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 12 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 60%–80%) to yield the title compound (36.3 mg, 84%) as a brown oil. Rf: 0.13 (70% ethyl acetate/hexanes) 1H NMR (500 MHz, CDCl3): δ 7.88 (d, J = 7.5 Hz, 2H), 7.73 (d, J = 12.6 Hz, 1H), 7.47–7.40 (m, 3H), 5.88 (d, J = 12.6 Hz, 1H), 3.76 (at, J = 4.8 Hz, 4H), 3.40 (at, J = 4.2 Hz, 4H) 13C NMR (151 MHz, CDCl3): δ 189.3, 152.9, 140.3, 131.3, 128.3, 127.6, 92.6, 66.3 IR (cm−1): 2922, 2853, 1641, 1597, 1582, 1547, 1444, 1372, 1313, 1283, 1207, 1115, 1055, 1022, 927, 885, 760, 705, 662 ESI-HRMS (m/z): [M+H]+ calc’d for C13H16NO2+: 218.1176; found: 218.1179.

4.2.16. Indoline enaminone of acetophenone (4i)

The title compound was prepared according to the general procedure with acetophenone (23 μL, 0.20 mmol, 1.0 equiv) and indoline Gold’s reagent (5h, 69 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 12 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 60%–80%) to yield the title compound (39.1 mg, 78%) as a yellow solid. Rf: 0.19 (20% ethyl acetate/hexanes) 1H NMR (500 MHz, CDCl3): δ 8.41 (d, J = 12.4 Hz, 1H), 7.96 (d, J = 7.1 Hz, 1H), 7.51–7.43 (m, 3H), 7.20 (d, J = 7.7 Hz, 2H), 7.10 (d, J = 7.9 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 6.04 (d, J = 12.6 Hz, 1H), 3.94 (t, J = 8.4 Hz, 2H), 3.26 (t, J = 8.4 Hz, 2H) 13C NMR (151 MHz, CDCl3): δ 189.1, 143.9, 141.5, 140.0, 131.5, 131.2, 128.4, 128.1, 127.8, 125.7, 123.2, 109.2, 96.6, 48.3, 27.7 IR (cm−1): 2924, 1643, 1579, 1542, 1598, 1496, 1258, 1208, 1052, 883, 747, 703 ESI-HRMS (m/z): [M+H]+ calc’d for C17H16NO+: 250.1226; found: 250.1221.

4.2.17. Osimertinib precursor (4j)

The title compound was prepared according to the general procedure with N-Me-3-acetylindole26 (35 mg, 0.20 mmol, 1.0 equiv) and morpholine Gold’s reagent (5a, 36 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 2 h. The yellow oil was washed with pentane (3 × 2 mL), the pentane layer was discarded, and the oil was dried under vacuum (ca.100 mtorr) to reveal the title compound as a yellow-orange foam (43.2 g, 94%). Rf: 0.12 Ethyl acetate 1H NMR (400 MHz, CDCl3): δ 8.40–8.37 (m, 1H), 7.76 (d, J = 12.5 Hz, 1H), 7.67 (s, 1H), 7.33–7.25 (m, 3H), 5.64 (d, J = 12.5 Hz, 1H), 3.81 (s, 3H), 3.00 (brs, 6H) 13C NMR (151 MHz, CDCl3): δ 184.9, 152.0, 137.5, 133.0, 126.9, 123.2, 122.7, 122.6, 122.2, 121.6, 118.3, 109.5, 94.1, 33.4 IR (cm−1): 2919, 1635, 1574, 1549, 1523, 1466, 1369, 1331, 1225, 1081, 1048, 1011, 884, 791, 748, 574 ESI-HRMS (m/z): [M+H]+ calc’d for C14H17N2O+: 229.1335; found: 229.1336.

4.2.18. Indoline enaminone of dihydro-β-ionone (4k)

The title compound was prepared according to the general procedure with dihydro-β-ionone (42 μL, 0.20 mmol, 1.0 equiv) and indoline Gold’s reagent (5h, 69 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 1.5 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 10%–30%) to yield the title compound (36.4 mg, 56%) as a yellow solid. Rf: 0.22 (20% ethyl acetate/hexanes) 1H NMR (500 MHz, CDCl3): δ 8.12 (d, J = 13.0 Hz, 1H), 7.18 (d, J = 7.5 Hz, 2H), 7.01 (d, J = 8.0 Hz, 1H), 6.94 (t, J = 7.4 Hz, 1H), 5.34 (d, J = 13.0 Hz, 1H), 3.82 (t, J = 8.5 Hz, 2H), 3.23 (t, J = 8.5 Hz, 2H), 2.55–2.52 (m, 2H), 2.37–2.33 (m, 2H), 1.92 (t, J = 6.5 Hz, 2H), 1.64 (s, 3H), 1.61–1.56 (m, 2H), 1.45–1.42 (m, 2H), 1.02 (s, 6H) 13C NMR (126 MHz, CDCl3): δ 198.7, 144.1, 139.3, 136.8, 131.0, 128.1, 127.7, 125.7, 122.8, 108.8, 100.5, 48.1, 42.4, 40.0, 35.2, 32.9, 28.7, 27.7, 24.2, 20.0, 19.7 IR (cm−1): 2923, 2863, 1665, 1583, 1300, 1262, 1111, 748, 703 ESI-HRMS (m/z) [M+H]+ calc’d for C22H30NO+: 324.2322; found: 324.2346.

4.2.19. Piperidine enaminone of geranylacetone (4l)

The title compound was prepared according to the general procedure with geranylacetone (15 μL, 0.20 mmol, 1.0 equiv) and piperidine Gold’s reagent (5f, 54 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 2 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 40%–60%) to yield the title compound (27.2 mg, 62%) as a yellow solid. Rf: 0.29 (60% ethyl acetate/hexanes) 1H NMR (500 MHz, CDCl3): δ 7.48 (d, J = 12.8 Hz, 1H), 5.14–5.06 (m, 3H), 3.23 (brs, 4H), 2.34–2.28 (m, 4H), 2.07–2.02 (m, 3H), 1.97–1.94 (m, 1H), 1.67–1.58 (m, 15H) 13C NMR (126 MHz, CDCl3): δ 198.2, 151.3, 135.6, 131.4, 124.7, 124.5, 123.9, 39.8, 32.1, 26.9, 26.8, 25.8, 25.8, 24.5, 24.4, 24.2, 23.5, 17.8, 16.1. IR (cm−1): 2924, 2855, 2348, 2166, 1610, 1563, 1447, 1369, 1239, 1100, 1026, 983, 852, 765 ESI-HRMS (m/z): [M+H]+ calc’d for C19H32NO+: 290.2478; found: 290.2501.

4.2.20. Morpholine enaminone of γ-butyrolactone (4m)

The title compound was prepared according to the general procedure with γ-butyrolactone (44 μL, 0.20 mmol, 1.0 equiv) and morpholine Gold’s reagent (5g, 54 mg, 0.22 mmol, 1.1 equiv) then heated at 65 °C for 6 h. The crude oil was purified by flash column chromatography on silica gel (ethyl acetate/hexanes = 40%–60%) to yield the title compound (36.4 mg, 74%) as a yellow solid. Rf: 0.15 (90% ethyl acetate/hexanes) 1H NMR (400 MHz, CDCl3): δ 7.11 (t, J = 2.0 Hz, 1H), 4.27 (t, J = 7.6 Hz, 2H), 3.72 (t, J = 4.4 Hz, 4H), 3.42 (t, J = 4.4 Hz, 4H), 3.01 (dd, J = 8.0, 2.0 Hz, 2H) 13C NMR (151 MHz, CDCl3): δ 175.5, 145.2, 88.2, 66.6, 64.6, 49.8, 26.2 IR (cm−1): 2922, 2855, 1723, 1622, 1445, 1363, 1270, 1230, 1158, 1114, 1021, 1003, 863, 747 ESI-HRMS (m/z): [M+H]+ calc’d for C9H14NO3+: 184.0968; found: 184.0980.

4.2.21. Scalable synthesis of dimethyl enaminone of 2-butanone (4m)

To a flame-dried 5-L round-bottomed flask equipped with a magnetic stir bar was added solid LiO-t-Bu (88.1 g, 1.1 mol, 1.1 equiv). To the stirred solid, was added THF (2.0 L, 0.5 M) via cannula, and this mixture was allowed to stir at room temperature for 10 min to allow for complete dissolution of LiO-t-Bu solid. 2-butanone (72.1 g, 1.0 mol, 1.0 equiv) was added dropwise at room temperature to the reaction mixture over 15 min, resulting in a light yellow mixture. After stirring at room temperature for 30 min, methyl Gold’s reagent (5a, 182 g, 1.1 mol, 1.1 equiv) was added in 5 portions over 30 min. The reaction vessel was fitted with an oven-dried reflux condenser and transferred to a heating mantle that was then warmed to a gentle reflux.

After stirring at reflux for 12 h, the reaction apparatus was removed from the heating mantle and allowed to cool to room temperature. Once at room temperature, the reaction was diluted with sat. aq. NH4Cl (2.5 L) and chloroform (3 L). The layers were separated, and the aqueous layer was extracted with chloroform (3 × 2 L). The combined organics were washed with brine (5 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure by rotary evaporation to give the crude enaminone as a black oil. The black oil was purified by fractional distillation through a 5 cm vigreux column to reveal the title compound as a yellow liquid (92.3 g, 73%). Boiling point: 82 °C at 200 mtorr Rf: 0.11 (90% ethyl acetate/hexanes) 1H NMR (400 MHz, CDCl3): δ 7.50 (d, J = 12.7 Hz, 1H), 5.01 (d, J = 12.7 Hz, 1H), 2.90 (brs, 6H), 5.01 (d, J = 12.7 Hz, 1H), 2.33 (q, J = 7.5 Hz, 2H), 1.09 (t, J = 7.5 Hz, 3H) 13C NMR (151 MHz, CDCl3): δ 199.0,152.3, 95.3, 44.8, 36.9, 30.4 10.0 IR (cm−1): 2931, 2053, 1562, 1433, 1354, 1283, 1221, 1103, 1036, 979, 763 ESI-HRMS (m/z): [M+H]+ calc’d for C7H14NO+: 128.1070; found: 128.1001.

4.2.22. E-diene (7a)

To a flame-dried 100-mL round-bottomed flask equipped with a magnetic stir bar was added LiCl (100.1 mg, 2.36 mmol, 0.3 equiv). The reaction flask was placed under vacuum and heated with a heat gun for 2 min and then back filled with nitrogen (This process was repeated three times). After the flask was cooled to room temperature, the flask was back filled with nitrogen and diluted with THF (26 mL, 0.3 M).

2,2,6,6-tetramethylpiperidine (1.6 mL, 9.43 mmol, 1.2 equiv) was added dropwise over 5 min at room temperature to the vigorously stirred reaction mixture. The reaction vessel was transferred to a −20 °C dry-ice acetone bath. After stirring at this temperature for 10 min, n-BuLi (3.5 mL, 8.7 mmol, 1.1 equiv) was added dropwise over 5 min, which resulted in a pale yellow solution. Once 25 min had elapsed, the reaction was cooled to −78 °C in a saturated dryice acetone bath, and DMPU (0.95 mL, 7.9 mmol, 1.0 equiv) was added dropwise over 2 min, which resulted in a light orange mixture. The reaction mixture was allowed to stir at −78 °C for 30 min.

In a separate flame-dried 25-mL round-bottomed flask was added enaminone 4b (1.0 g, 7.9 mmol, 1.0 equiv) that was then diluted with THF (5 mL, 1.6 M). This solution was added dropwise over 5 min at −78 °C to the vigorously stirred reaction mixture, which resulted in a red-orange reaction mixture. After stirring at −78 °C for 30 min, a solution of TIPSCl (1.7 mL, 7.7 mmol, 0.98 equiv) in THF (10 mL, 7.7 M) was added to the reaction mixture dropwise over 5 min, which resulted in a light yellow solution. Following stirring at −78 °C for 10 min, the reaction vessel was transferred to a 0 °C ice-water bath.

After stirring at 0 °C for 2 h, sat. aq. NH4Cl (10 mL) was added and the layers were separated. The aqueous layer was extracted with pentane (3 × 25 mL). The combined organics were washed with sat. aq. NaHCO3 (20 mL), brine (3 × 30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure by rotary evaporation to yield an orange oil as a >20:1 (E:Z) mixture of diastereomers. The crude mixture was purified by rapid fractional distillation (<5 min) with a heat gun to reveal the title compound as a yellow liquid (>20:1 E:Z, 1.32 g, 59%) Boiling point: 80–84 °C at 200 mtorr Rf: 0.8 (5% Et2O/0.5% Et3N/pentane) 1H NMR (600 MHz, CDCl3): δ 6.66 (d, J = 15.6 Hz, 1H), 4.89 (d, J = 15.6, 1H), 4.36 (q, J = 7.0 Hz, 1H), 2.72 (s, 6H), 1.57 (d, J = 8.4 Hz, 3H), 1.23–1.17 (m, 3H), 1.11 (s, 9H), 1.10 (s, 9H) 13C NMR (151 MHz, CDCl3): δ 149.5, 140.6, 95.3, 92.2, 40.8, 18.4, 13.1 IR (cm−1): 2939, 2863, 2119, 1653, 1561, 1463, 1421, 1358, 1284, 1224, 1107, 1042, 990, 916, 882, 850 ESI-HRMS (m/z): [M+H]+ calc’d for C16H34NOSi+: 284.2404; found: 284.2401.

4.2.23. Z-diene (7b)

An evacuated flame dried 50-mL round-bottomed flask equipped with magnetic stir bar and Schlenk adaptor was brought into a glovebox. Once in the glovebox, the flask was filled with nitrogen atmosphere. Solid LiHMDS (1.45 g, 8.64 mmol, 1.1 equiv) was added and the flask was sealed. The reaction vessel was removed from the glovebox, and the flask was evacuated and backfilled with nitrogen three times. The Schlenk adaptor was replaced with a rubber septum and placed under a nitrogen atmosphere.

To the stirred solid LiHMDS was added THF (16 mL, 0.5 M) and then placed in a saturated dry-ice acetone bath cooled to −78 °C. Enaminone 4b (1.0 g, 7.9 mmol, 1.0 equiv) was added dropwise over 5 min to the reaction mixture at −78 °C, which resulted in an orange mixture. After stirring at −78 °C for 30 min, DMPU (2.9 mL, 24 mmol, 3.0 equiv) was added dropwise over 5 min, which resulted in a light orange reaction mixture.

Once 30 min had elapsed, TIPSCl (1.9 mL, 8.6 mmol, 1.1 equiv) was added dropwise to the reaction mixture over 5 min, which resulted in a yellow reaction mixture. The reaction vessel was transferred to a 0 °C ice-water bath.

After stirring at 0 °C for 2 h, sat. aq. NH4Cl (10 mL) was added and the layers were separated. The aqueous layer was extracted with pentane (3 × 25 mL). The combined organics were washed with sat. aq. NaHCO3 (20 mL), brine (3 × 30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure by rotary evaporation to yield an orange oil as a 1:11 (E:Z) mixture of diastereomers. The crude mixture was purified by rapid fractional distillation (<5 min) with a heat gun to reveal the title compound as a yellow liquid (1:10 E:Z, 1.4 g, 63%) Boiling point: 80–84 °C at 200 mtorr Rf: 0.8 (5% Et2O/0.5% Et3N/pentane) 1H NMR (600 MHz, CDCl3): δ 6.37 (d, J = 13.5 Hz, 1H), 4.73 (d, J = 13.5 Hz, 1H) 4.43 (q, J = 8.4 Hz, 1H), 2.65 (s, 6H), 1.62 (d, J = 6.8 Hz, 3H), 1.26–1.20 (m, 3H), 1.13 (s, 9H), 1.12 (s, 9H) 13C NMR (151 MHz, CDCl3): δ 150.8, 139.5, 98.8, 98.3, 40.8, 18.3, 13.8 IR (cm−1): 2943, 2865, 1993, 1648, 1580, 1464, 1350, 1329, 1193, 1039, 937, 882, 937, 801 ESI-HRMS (m/z): [M+H]+ calc’d for C16H34NOSi+: 284.2404; found: 284.2403.

Supplementary Material

Supplementary Material

Acknowledgments

Yale University and the NSF (GRF to A.W.S.) are acknowledged for financial support. C. L. B. M. gratefully acknowledges the Arthur Fleischer Undergraduate Summer Research Fellowship in Chemistry.

Footnotes

Appendix A. Supplementary data

Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.tet.2017.03.092.

References

  • 1.Nicolaou KC, Snyder SA, Montagnon T, Vassilikogiannakis G. Angew Chem, Int Ed 2002;41:1668–1698. [DOI] [PubMed] [Google Scholar]
  • 2.Danishefsky S, Kitahara T. J Am Chem Soc 1974;96:7807–7808. [Google Scholar]
  • 3.For pioneering work using enaminones in diene synthesis, see:Kozmin SA, Rawal VH. J Org Chem 1997;62:5252e5253;Kozmin SA, Janey JM, Rawal VH. J Org Chem 1999;64:3039–3052.
  • 4.For select examples of Danishefsky-type dienes in total synthesis, see:Danishefsky S Acc Chem Res. 1981;14:400–406;Pudukulathan Z, Manna S, Hwang S-W, et al. J Am Chem Soc. 1998;120: 11953–11961;Bernardelli P, Moradei OM, Friedrich D, et al. J Am Chem Soc. 2001;123: 9021–9032;Mingji D, Danishefsky SJ. J Am Chem Soc. 2007;129:3498;Smith AB III, Razler TM, Ciavarri JP, Hirose T, Ishikawa T, Meis RM. J Org Chem. 2008;73:1192–1200;Danishefsky SJ, Zhang Y. J Am Chem Soc. 2010;132:9567–9569;Jewett JC, Rawal VH. Angew Chem, Int Ed. 2010;49:8682–8685;Pronin SV, Shenvi RA. J Am Chem Soc. 2012;134:19604–19606.
  • 5.For select examples of Rawal-type dienes in total synthesis, see:Kozmin SA, Rawal VH. J Am Chem Soc. 1998;120:13523–13524;Kozmin SA, Rawal VH. J Am Chem Soc. 1999:9562–9573;Paczkowski R, Maichle-Möossmer C, Maier ME. Org Lett. 2000;2:3967–3969;Kozmin SA, Iwama T, Huang Y, Rawal VH. J Am Chem Soc. 2002;124: 4628–4641;Smith AB III, Basu K, Bosanac T. J Am Chem Soc. 2007;129:14872–14874;Hayashida J, Rawal VH. Angew Chem, Int Ed. 2008;47:4373–4376;Tiefenbacher K, Mulzer J. Angew Chem, Int Ed. 2008;47:6199–6200;Petronijevic FR, Wipf P. J Am Chem Soc. 2011;133:7704–7707;Buchanan GS, Cole KP, Tang Y, Hsung RP. J Org Chem. 2011;76:7027–7039;Mukai K, Urabe D, Kasuya S, Aoki N, Inoue M. Angew Chem, Int Ed. 2013;52: 5300–5304;Reiher CA, Shenvi RA. J Am Chem Soc. 2017;139:3647–3650.
  • 6.For reviews on the synthesis and utility of enaminones, see:Greenhill JV. Chem Soc Rev. 1977;6:277–294;Elassar A-ZA, El-Khair AA. Tetrahedron. 2003;59:8463–8480.
  • 7.For a review on the therapeutic potential of enaminones, see: Edafiogho IO, Kombian SB, Ananthalakshmi KVV, et al. J Pharm Sci. 2007;96:2509–2531. [DOI] [PubMed] [Google Scholar]
  • 8.For a review on the use of enaminones in heterocycle synthesis, see: Negri G, Kascheres C, Kascheres AJ J Heterocycl Chem. 2004;41:461–491. [Google Scholar]
  • 9.Martin JC, Barton KR, Gott PG, Meen RH. J Org Chem. 1966;31:943–946. [Google Scholar]
  • 10.For select recent reports of transition metal-catalyzed reactions involving enaminones, see:Ge H, Niphakis MJ, Georg GL. J Am Chem Soc. 2008;130: 3708–3709;Yu Y-Y, Bi L, Georg GL. J Org Chem. 2013;78:6163–6169;Kim WY, Georg GL. Org Lett. 2014;16:1574–1577;Jiang Y, Liang G, Zhang C, Loh T-P. Eur J Org Chem. 2016:3326–3330;Zhou S, Wang J, Wang L, Kehao CS, Zhu J. Angew Chem, Int Ed. 2016;55: 9384–9388.
  • 11.Boyer J, Arnoult E, Médebielle M, Guillemont J, Unge J, Jochmans D. J Med Chem. 2011;54:7974–7985. [DOI] [PubMed] [Google Scholar]
  • 12.Bredereck H, Effenberger F, Botsch H. Chem Ber. 1965;97:3397–3406. [Google Scholar]
  • 13.(a) Mock WL, Tsou H-R. J Org Chem. 1981;46:2557–2561; [Google Scholar]; (b) Kim Y-H, Lee K-Y, Oh C-Y, Yang J-G, Ham W-H. Tetrahedron Lett. 2002;43: 837–841; [Google Scholar]; (c) Li L-H, Tius MA. Org Lett. 2002;4:1637–1640. [DOI] [PubMed] [Google Scholar]
  • 14.Schuppe AW, Newhouse TR. J Am Chem Soc. 2017;139:631–634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gupton JT, Andrew SS, Colon C. Synth Commun. 1982;12:35–41. [Google Scholar]
  • 16.(a) Gupton JT, Colon C, Harrison CR, Lizzi MJ, Polk DE. J Org Chem. 1980;45: 4522–4524; [Google Scholar]; (b) Gupton JT, Andrew SS, Colon C. Synth Commun. 1982;12:939–946. [Google Scholar]
  • 17.Gold H Angew Chem. 1960;24:956–959. [Google Scholar]
  • 18.(a) Xu X AZD9291 Intermediate and Preparation Method Thereof. Chinese Patent Application CN 104910049, September 16, 2015 [Google Scholar]; (b) Hughes DL. Org Process Res Dev. 2016;20:2028–2042. [Google Scholar]
  • 19.For reviews on stereoselectivity in Diels-Alder reactions, see:Martin JG, Hill RK. Chem Rev. 1961;61:537–562;Herndon WC. Chem Rev. 1972;72:157–179.
  • 20.(a) Watanabe Y, Shimada N, Anada M, Hashimoto S. Tetrahedron Asymmetry. 2014;25:64–73; [Google Scholar]; (b) Chen M, Hartwig JF. J Am Chem Soc. 2015;137:13972–13979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.For select examples of controlling enolate geometry, see:Hall PL, Gilchrist JH, Collum DB. J Am Chem Soc. 1991;113:9571–9574;Xie L, Isenberger KM, Held G, Dahl LM. J Org Chem. 1997;62:7516–7519;Lucht BL, Collum DB. Acc Chem Res. 1999;32:1035–1042;Xie L, Vanlandeghem K, Isenberger KM, Bernier C. J Org Chem. 2003;68: 641–643;Pratt LA, Streitwieser A. J Org Chem. 2003;68:2830–2838;Godenschwager PF, Collum DB. J Am Chem Soc. 2007;129:12023–12031;Godenschwager PF, Collum DB. J Am Chem Soc. 2008;130:8726–8732.
  • 22.Corey EJ, Gross AW. Tetrahedron Lett. 1984:495–498. [Google Scholar]
  • 23.For discussion of kinetics and transition state geometry of enolates, see:Narula AS. Tetrahedron Lett. 1981;22:4119–4222;Moreland DW, Dauben WG. J Am Chem Soc. 1985;107:2264–2273.
  • 24.Borel C, Hegedus LS, Krebs J, Satoh Y. J Am Chem Soc. 1987;109:1101–1105. [Google Scholar]
  • 25.Carlier PR, Lockshin MP, Filosa MP. J Org Chem. 1994;59:3232–3236. [Google Scholar]
  • 26.Davies JR, Kane PD, Moody CJ, Slawin AMZ. J Org Chem. 2005;70:5840–5851. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material

RESOURCES